News
-
-
PRESS RELEASE
THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
THX Pharma launches a €8 million capital increase to fund rare neurological drug development, with 75.5% commitments secured. Batten-1 and TX01 to lead clinical and commercial endeavors with strategic shift to international markets. Investment opportunities for various tax schemes -
-
PRESS RELEASE
Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy -
-
PRESS RELEASE
Steyr Motors increases revenue by over 15% in the first nine months of 2025 – further increasing strong order backlog of more than EUR 300 million
Steyr Motors AG increases revenue by over 15% in the first nine months of 2025, with a strong order backlog exceeding EUR 300 million. Strategic international expansion and growth opportunities in diversified markets -
-
-
PRESS RELEASE
BUREAU VERITAS - Robust and consistent revenue performance delivered in Q3 2025; FY 2025 outlook reaffirmed
Bureau Veritas delivers robust Q3 2025 revenue performance, reaffirms FY 2025 outlook. Key highlights: steady organic growth, operational resilience, strategic focus. CEO confirms robust performance across entire portfolio, continuing LEAP | 28 strategy execution -
